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Biocatalytic Synthesis of Chiral N-Functionalized Amino Acids 
Julia F. Hyslop,[a,b] Sarah L. Lovelock,[b,c] Peter W. Sutton,[d,e] Kristin K. Brown,[f] Allan, J. B. Watson,*[a,g] 
and Gheorghe-Doru Roiban*[b] 
 
Abstract: N-Functionalized amino acids are important building 
blocks for the preparation of diverse bioactive molecules including 
peptides. The development of sustainable manufacturing routes to 
chiral N-alkylated amino acids remains a significant challenge in the 
pharmaceutical and fine chemical industries. Herein we report the 
discovery of a structurally diverse panel of biocatalysts which 
catalyze the asymmetric synthesis of N-alkyl amino acids via the 
reductive coupling of ketones and amines. Reactions have been 
performed on a gram scale to yield optically pure N-alkyl 
functionalized products in high yields.   
Chiral non-natural amino acids represent a class of molecules 
which have gained increased attention within the pharmaceutical 
and agrochemical industries in recent years. They are key 
components of many active pharmaceutical ingredients (APIs) 
and have been incorporated into various biologically active 
peptides[1] such as cyclosporins,[2] vancomycin,[3] and 
actinomycins,[4] to generate analogues that can display 
enhanced bioavailability and metabolic stability. As a result, the 
development of sustainable and cost-effective methods for the 
synthesis of functionalized α-amino acid derivatives is highly 
desirable. Current chemical methods for the synthesis of N-
functionalized amino acids rely on either N-alkylation processes, 
which often require toxic reagents and hazardous solvents, or 
reductive amination which utilizes stoichiometric quantities of 
hazardous hydrides and requires complex work-up procedures 
which generate significant waste.[5] Numerous asymmetric 
reductive amination strategies have also been reported[6] 
including biomimetic routes,[7] however they are limited by their 
narrow substrate range, the use of heavy metals, and the 
requirement to pre-form imine intermediates to avoid undesired 
ketone reduction.[5a] Biocatalytic approaches to chiral amino acid 
synthesis provide a ‘greener alternative’ to traditional chemical 
methods. Ammonia lyases[8] and amino acid dehydrogenases[9] 
have been successfully employed in the synthesis of a broad 
range of primary amino acids, however, they are limited to the 
use of ammonia as a nitrogen source. In recent years, a family 
of NAD(P)+ dependent oxidoreductases including imine 
reductases (IREDs),[10] opine dehydrogenases,[11] and reductive 
aminases,[12] have emerged as useful tools for the asymmetric 
synthesis of a broad range of amines. Despite the substrate 
promiscuity of these classes of enzymes, there are few 
examples of catalysts with activity towards keto acids for the 
synthesis of N-functionalized amino acids.[12, 13] 
N-Methylamino acid dehydrogenases (NMAADHs, EC 
1.5.1.1 and EC 1.5.1.21) (also known as dPkAs or Δ1-piperidine-
2-carboxylate (Pyr2CR)/ Δ1-pyrrolidine-2-carboxylate reductases 
(Pip2CR)),[14] ketimine reductases (KIREDs, EC 1.5.1.25)[15] and 
Δ1-pyrroline-5-carboxylate reductases (P5CR, EC 1.5.1.2)[16] are 
structurally unrelated enzyme classes which catalyze the 
reduction of cyclic imino acids in Nature (Figure 1).[17] 
 
Figure 1. Examples of reductive aminations catalysed by: imine reductases 
(IREDs), N-methylamino acid dehydrogenases (NMAADHs), ketimine 
reductases (KIREDs), amino acid dehydrogenases (AADHs), fungal Δ1-
pyrroline-5-carboxylate reductases (P5CR), and opine dehydrogenases 
(ODHs). 
NMAADHs have also been reported to promote the 
intermolecular coupling of α-keto acids with methylamine,[18] 
however, their widespread use as biocatalysts for the synthesis 
of enantiopure N-methyl amino acids has been limited by their 
requirement for large excesses of the amine coupling partner 
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and their narrow substrate specificity. Herein, we have evaluated 
a panel of diverse NMAADHs KIREDs and P5CRs  for the 
reductive amination of α-keto acids. We have shown that 
together these enzymes can accept a broad range of both 
aliphatic and aromatic amines and we demonstrate their 
synthetic utility in the synthesis of N-functionalized amino acids 
on a preparative scale. Although NMAADHs, KIREDs and 
P5CRs catalyze similar reactions in Nature, there is low 
sequence homology between clusters (Figure 2 and Figure S8). 
While all exist as dimers and contain an NADPH binding domain, 
they have diverse folding architectures.  
We selected seven enzymes (En01-En07) from three distinct 
clusters for evaluation. En01-En03 (from Pseudomonas 
putida,[14c] P. syringae[19] and P. fluorescens,[20] respectively) 
belong to the NMAADH cluster, En04-En06 (from Rattus 
norvegicus,[21] Homo sapiens,[15c] and Bos taurus[16a] 
respectively) are KIREDs, and the fungal enzyme En07 (from 
Neurospora crassa[16a]) is from the P5CR superfamily. The 
selected enzymes are not only structurally diverse but also 
originate from different species (mammalian, fungal, and 
bacterial) (See Table S1). En01-07 were overexpressed in E. 
coli, purified and the activity towards the reductive coupling of 
phenyl pyruvate 1a and amines 2a-g was evaluated using HPLC 
analysis. Interestingly, the different classes of enzymes 
displayed complementary reactivities and together were able to 
tolerate a range of primary amine substrates (Table 1). Under 
optimized reaction conditions (200 mM Tris HCl buffer pH 8.5) 
using 10 equivalents of methylamine (2a), the NMAADHs (En01-
En03) proceed with almost complete conversion to the product 
3a. En01-En03 also accept amines 2b-2c and have good activity 
towards propargylamine (2d) and cyclopropylamine (2e). The 
KIREDs (En04-En06) have the broadest substrate tolerance and 
are active towards larger amines containing aromatic 
functionality such as 2f despite of reduced activity for 2g. Unlike 
the NMAADHs and KIREDs, P5CR En07 has a preference for 
propargylamine (2d) over methylamine (2a) and the product 3d 
is formed with 82% conversion. n-Propylamine, i-propylamine, 
dimethylamine, and aniline derivatives were not tolerated by any 
of the enzymes evaluated. All biotransformations were (S)-
selective and yielded secondary amine products with excellent 
ee as confirmed by chiral HPLC and comparison to optically 
 
Table 1. Comparison of enzymatic reductive amination activity between phenyl pyruvate (1a) with different amines (2).[a] 
 
Entry Amine Amine 
Equiv. 
Product En01 En02 En03 En04 En05 En06 En07  
conv.[b] ee[c] conv.[b] ee[c] conv.[b] ee[c] conv.[b] ee[c] conv.[b] ee[c] conv.[b] ee[c] conv.[b] ee[c] 
1 2a, R=Me 10 3a 97% >99% 98% >99% 98% >99% 51% >99% 81% >99% 32% >99% 33% >99% 
2 2a, R=Me 1 3a 55% >99% 47% >99% 50% >99% 14% >99% 23% >99% 10% >99% 8% >99% 
3 2b, R=Et 10 3b 16% >99% 6% >99% 5% >99% 5% >99% 9% >99% 2% nd[d] 2% nd[d] 
4 2b, R=Et 1 3b 2% nd[d] 1% nd[d] 1% nd[d] -[e]  -[e] -[e] --[e] 
5 2c, R=Allyl 10 3c 12% >99% 6% 97% 5% >99% 16% >99% 30% >99% 10% >99% 23 % >99% 
6 2c, R=Allyl 1 3c 2% nd[d] 1% nd[d] 1% nd[d] 3% nd[d] 5% >99% 2% nd[d] 3% nd[d] 
7 2d, R=Propargyl 10 3d 92% >99% 52% >99% 58% >99% 19% >99% 24% >99% 26% >99% 82% >99% 
8 2d, R=Propargyl 1 3d 20% >99% 9% >99% 10% >99% 2% nd[d] 3% nd[d] 2% nd[d] 21% >99% 
9 2e, R=Cyclopropyl 10 3e 59% >99% 27% >99% 29% >99% 43% >99% 79% >99% 29% >99% 2% nd[d] 
10 2e, R=Cyclopropyl 1 3e 32% >99% 11% >99% 11% >99% 11% >99% 23% >99% 1% nd[d] -[e] 
11 2f, R=Benzyl 10 3f -[e] -[e] -[e] 18% >99% 17% >99% 7% >99% -[e] 
12 2f, R=Benzyl 1 3f -[e] -[e] -[e] 7% >99% 18% >99% 4% >99% -[e] 
13 2g, R=CH2CH2Ph 10 3g -[e] -[e] -[e] 3% nd[d] 5% >99% 1% nd[d] 2% nd[d] 
14 2g, R=CH2CH2Ph 1 3g -[e]  -[e] -[e] 3% nd[d] 3% nd[d] 2% nd[d] 1% nd[d] 
[a]Reaction parameters: keto acid 1a (10 mM), amines 2a-g (10 mM or 100 mM), NADPH (1 mM), En01-07 (0.1 µM), GDH (1 mg/mL), D-glucose (30 mM), Tris 
HCl buffer (200 mM, pH 8.5), 25 °C, 24 h. [b] Conversion to the (S)-product determined by HPLC. [c]Determined by chiral HPLC and absolute configuration 
assigned in comparison to racemic and authentic (S)-product standards . [d]Not determined due to low conversion. [e]No conversion to the product observed. 
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pure standards. Biotransformations performed using equimolar 
ratios of ketone and amine gave reduced conversions to the 
amino acid products, due to a combination of increased recovery 
of keto acid starting materials and low levels of competing  
enzyme-catalyzed ketone reduction (< 15%). Nevertheless, in 
favourable cases substantial conversions could be acheived (up 
to 55%) using stoichiometric substrate ratios, with considerable 
potential to further optimize these processes through 
combinations of reaction engineeing and enzyme evolution. 
The substrate promiscuity of En01-En07 was further evaluated 
using α-keto acids 2-oxo-4-phenylbutanoic acid (1b) and 3-(4-
hydroxy-3-methoxyphenyl)-2-oxopropanoic acid (1c), with 
methylamine (2a) and propargylamine (2d) as co-substrates 
(Supporting Information). All biocatalysts tolerated substrates 
with an increased linker length (1b), with product yields 
comparable to reactions with substrate 1a. Keto acid 1c 
containing substituted aromatic groups was also tolerated by all 
enzymes screened.  
To demonstrate the practical utility of these biocatalysts for the 
synthesis of N-functionalized amino acids, selected reactions 
were performed on a preparative scale using clarified lysates 
containing an enzyme from each of the families evaluated. 
Reactions catalyzed by En01 and En04 resulted in excellent 
yields of N-methylphenylalanine (3a) and N-benzylphenylalanine 
(3f) respectively. The conversion to 3f is higher than previously 
reported using purified En04 (Table 1) and this can be attributed 
to higher catalyst loading. The En07-catalyzed reaction between 
1a and propargylamine (2d) resulted in a modest yield, due to 
competing ketone reduction catalyzed by endogenous E. coli 
enzymes present in the cell lysate. 
 
Table 2. Preparative scale synthesis of N-alkyl amino acids 3a, d, and f.[a]  
Enzyme 
Amount 
of 1a 
(g)/ 
Amine 
Product 
Product 
conv 
(%)[b] / 
isolated 
yield (%) 
3-Phenyl 
lactic acid 
conv 
(%)[c] 
ee 
(%) 
(S) 
En01 3.0/2a 
 
3a 
82/80 5 >99 
En04 0.2/2f 
3f 
98/9[d] 2 >99 
En07 0.2/2d 
3d 
32/21 67 >99 
[a]Reaction parameters: Phenyl pyruvate 1a (10 mM), amine 2a (700 mM) or 
2d, 2f (100 mM), En01 (60 mL cell free extract from 7.5 g wet cell pellet), 
En04, En07 (40 mL cell free extract from 5.0 g wet cell pellet), NADPH (1 
mM), GDH (1 mg/mL), D-glucose (20 mM), 25 °C, 24 h. Tris HCl buffer (200 
mM, pH 8.5), 27 h for entry 1 and 24 h for entries 2-3. [b]% HPLC conversion 
to desired product 3. [c]% HPLC conversion to 3-phenyl lactic acid. [d]Product 
isolation was performed using preparative LC-MS (mass-directed 
autopurification system, emphasizing purity over yield). 
 
To gain insights into the origins of reaction selectivities, we 
performed docking studies with N-methyl-L-phenylalanine (3a) 
using available crystal structures of En01, En05 and En07, 
representing each of the three oxidoreductase families 
investigated. The models reveal that hydrogen bonding 
interactions between the substrate/product carboxylate and a 
conserved active site arginine, position the Re-face of the imine 
intermediate adjacent to the nicotinamide ring of NADPH in a 
productive conformation for hydride transfer. However in P5CR 
En07, the carboxylate appears to interact with a threonine 
(Thr209) and the backbone NH of Thr154. All proteins also 
contain a conserved serine residue, which is suitably positioned 
to serve as a  proton donor (Figure 2).  
A B C
 
Figure 2. Models of En01 (A), En05 (B) and En07 (C) with the product (S)-N-methylphenyalalanine, 3a (yellow) docked into the active site. Models of the 
enzymes were generated using MOE modeling software and x-ray crystal structures available in the PDB, 2CWH (En01)[22], 4BVA (En05)[23] and 5BSF (En07)[24]. 
NADP+ is shown in cyan.  
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In summary, we have identified and evaluated a panel of 
biocatalysts from three distantly related enzyme classes for the 
synthesis of N-functionalized amino acids. Our study 
demonstrates the first examples of KIRED and P5CR catalyzed 
reductive amination reactions, and shows that these enzymes 
are useful biocatalysts with complimentary substrate specificities 
to NMAADHs. The synthetic utility of this enzyme panel has 
been demonstrated through gram-scale biotransformations.  
Although a ten-fold excess of amine was typically required to 
achieve high conversions, we have also demonstrated that 
biotransformations can be performed using 1 equivalent of 
amine, with significant levels of conversion achieved in 
favourable cases. It is anticipated that increased conversions 
and productivities can be achieved through a combination of 
reaction engineering and laboratory evolution,[25] leading to the 
development of industrially viable processes. The synthetic utility 
of this enzyme panel has also been demonstrated on a gram 
scale. Future work will focus on the acquisition and 
characterization of further family members as well as further 
improving the substrate scope and stability of these enzymes via 
directed evolution. 
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